Humoral and Cell-Mediated Immune Response in Colostrum from Women Diagnosed Positive for SARS-CoV-2
| dc.contributor.author | Narayanaswamy, Vignesh | |
| dc.contributor.author | Pentecost, Brian | |
| dc.contributor.author | Alfandari, Dominique | |
| dc.contributor.author | Chin, Emily | |
| dc.contributor.author | Minor, Kathleen | |
| dc.contributor.author | Kastrinakis, Alyssa | |
| dc.contributor.author | Lieberman, Tanya | |
| dc.contributor.author | Arcaro, Kathleen F. | |
| dc.contributor.author | Leftwich, Heidi | |
| dc.date | 2022-08-11T08:08:10.000 | |
| dc.date.accessioned | 2022-08-23T15:45:15Z | |
| dc.date.available | 2022-08-23T15:45:15Z | |
| dc.date.issued | 2021-08-11 | |
| dc.date.submitted | 2021-08-27 | |
| dc.identifier.citation | <p>Narayanaswamy V, Pentecost B, Alfandari D, Chin E, Minor K, Kastrinakis A, Lieberman T, Arcaro KF, Leftwich H. Humoral and Cell-Mediated Immune Response in Colostrum from Women Diagnosed Positive for SARS-CoV-2. Breastfeed Med. 2021 Aug 11. doi: 10.1089/bfm.2021.0082. Epub ahead of print. PMID: 34382820. <a href="https://doi.org/10.1089/bfm.2021.0082">Link to article on publisher's site</a></p> | |
| dc.identifier.issn | 1556-8253 (Linking) | |
| dc.identifier.doi | 10.1089/bfm.2021.0082 | |
| dc.identifier.pmid | 34382820 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14038/27486 | |
| dc.description.abstract | Objective: To evaluate the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in colostrum from women who tested positive for the virus. Methods: Between March and September 2020 we obtained bilateral colostrum samples collected on spot cards within 48 hours of delivery from 15 new mothers who had previously tested positive for SARS-CoV-2. Four of 15 women provided liquid colostrum, which was used for validating results obtained from spot cards. Archived bilateral colostrum samples collected from 8 women during 2011-2013 were used as pre-coronavirus disease 2019 (COVID-19) controls. All samples were tested for reactivity to the receptor binding domain (RBD) of the SARS-CoV-2 spike protein using an enzyme-linked immunosorbent assay that measures SARS-CoV-2 RBD-specific IgA, IgG, and IgM and for levels of 10 inflammatory cytokines (interferon-gamma [IFN-gamma], tumor necrosis factor-alpha, interleukin [IL]-1beta, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-13) using a multiplex electrochemiluminescent sandwich assay. Results: Our validation studies indicate that the levels of SARS-CoV-2-specific antibodies and the associated cytokines measured in liquid colostrum are comparable to levels eluted from spot cards. Bilateral colostrum samples from 73%, 73%, and 33% of the 15 COVID-19 mothers exhibited IgA, IgG, and IgM reactivity to RBD, respectively. In addition, symptomatic COVID-19 mothers had statistically significant elevated levels of 4 of the 10 inflammatory markers (IFN-gamma, IL-4, IL-6, and IL-12) compared to asymptomatic COVID-19 mothers. Conclusions: A strong humoral immune response is present in the colostrum of women who were infected with SARS-CoV-2 before delivering. The evolution and duration of the antibody response, as well as dynamics of the cytokine response, remain to be determined. Our results also indicate that future large-scale studies can be conducted with milk easily collected on paper spot cards. | |
| dc.language.iso | en_US | |
| dc.relation | <p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=34382820&dopt=Abstract">Link to Article in PubMed</a></p> | |
| dc.rights | Copyright Vignesh Narayanaswamy et al. 2021; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License [CC-BY] (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject | COVID-19 | |
| dc.subject | SARS-CoV-2 | |
| dc.subject | antibody | |
| dc.subject | breast milk | |
| dc.subject | breastfeeding | |
| dc.subject | colostrum | |
| dc.subject | cytokine | |
| dc.subject | Hemic and Immune Systems | |
| dc.subject | Immunology of Infectious Disease | |
| dc.subject | Infectious Disease | |
| dc.subject | Maternal and Child Health | |
| dc.subject | Microbiology | |
| dc.subject | Virus Diseases | |
| dc.title | Humoral and Cell-Mediated Immune Response in Colostrum from Women Diagnosed Positive for SARS-CoV-2 | |
| dc.type | Journal Article | |
| dc.source.journaltitle | Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine | |
| dc.identifier.legacyfulltext | https://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1294&context=covid19&unstamped=1 | |
| dc.identifier.legacycoverpage | https://escholarship.umassmed.edu/covid19/289 | |
| dc.identifier.contextkey | 24527831 | |
| refterms.dateFOA | 2022-08-23T15:45:15Z | |
| html.description.abstract | <p>Objective: To evaluate the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in colostrum from women who tested positive for the virus.</p> <p>Methods: Between March and September 2020 we obtained bilateral colostrum samples collected on spot cards within 48 hours of delivery from 15 new mothers who had previously tested positive for SARS-CoV-2. Four of 15 women provided liquid colostrum, which was used for validating results obtained from spot cards. Archived bilateral colostrum samples collected from 8 women during 2011-2013 were used as pre-coronavirus disease 2019 (COVID-19) controls. All samples were tested for reactivity to the receptor binding domain (RBD) of the SARS-CoV-2 spike protein using an enzyme-linked immunosorbent assay that measures SARS-CoV-2 RBD-specific IgA, IgG, and IgM and for levels of 10 inflammatory cytokines (interferon-gamma [IFN-gamma], tumor necrosis factor-alpha, interleukin [IL]-1beta, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-13) using a multiplex electrochemiluminescent sandwich assay.</p> <p>Results: Our validation studies indicate that the levels of SARS-CoV-2-specific antibodies and the associated cytokines measured in liquid colostrum are comparable to levels eluted from spot cards. Bilateral colostrum samples from 73%, 73%, and 33% of the 15 COVID-19 mothers exhibited IgA, IgG, and IgM reactivity to RBD, respectively. In addition, symptomatic COVID-19 mothers had statistically significant elevated levels of 4 of the 10 inflammatory markers (IFN-gamma, IL-4, IL-6, and IL-12) compared to asymptomatic COVID-19 mothers.</p> <p>Conclusions: A strong humoral immune response is present in the colostrum of women who were infected with SARS-CoV-2 before delivering. The evolution and duration of the antibody response, as well as dynamics of the cytokine response, remain to be determined. Our results also indicate that future large-scale studies can be conducted with milk easily collected on paper spot cards.</p> | |
| dc.identifier.submissionpath | covid19/289 | |
| dc.contributor.department | School of Medicine | |
| dc.contributor.department | Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine |

![Copyright Vignesh Narayanaswamy et al. 2021; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License [CC-BY] (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.](/themes/OR//images/creativecommons/cc-by.png)